{"id":"https://openalex.org/W4308403161","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0784","title":"784 Immune profiling of patients with advanced melanoma intratumorally treated with CV8102 as a single-agent or in combination with anti-PD-1 antibodies \u2013 results of a phase I trial expansion","display_name":"784 Immune profiling of patients with advanced melanoma intratumorally treated with CV8102 as a single-agent or in combination with anti-PD-1 antibodies \u2013 results of a phase I trial expansion","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308403161","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0784"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2022-sitc2022.0784","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0784","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0784","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A816.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A816.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Marina Gonzalez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123470","display_name":"CureVac (Germany)","ror":"https://ror.org/02q3n2241","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210123470"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Marina Gonzalez","raw_affiliation_strings":["CureVac AG, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CureVac AG, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210123470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072276143","display_name":"Peter Wengenmayer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123470","display_name":"CureVac (Germany)","ror":"https://ror.org/02q3n2241","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210123470"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter Wengenmayer","raw_affiliation_strings":["CureVac AG, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CureVac AG, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210123470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060671669","display_name":"\u0418\u0433\u043e\u0440\u044c \u0412\u044f\u0447\u0435\u0441\u043b\u0430\u0432\u043e\u0432\u0438\u0447 \u0421\u0430\u043c\u043e\u0439\u043b\u0435\u043d\u043a\u043e","orcid":"https://orcid.org/0000-0001-7150-5071","observed_orcids":["https://orcid.org/0000-0001-7150-5071"]},"institutions":[{"id":"https://openalex.org/I4210090957","display_name":"Russian Cancer Research Center NN Blokhin","ror":"https://ror.org/00ab9fg88","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210090957"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Igor Samoylenko","raw_affiliation_strings":["N.N. Blokhin Cancer Research Center, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N.N. Blokhin Cancer Research Center, Moscow, Russian Federation","institution_ids":["https://openalex.org/I4210090957"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033334588","display_name":"Sebastian Ochsenreither","orcid":"https://orcid.org/0000-0001-6024-4312","observed_orcids":["https://orcid.org/0000-0001-6024-4312"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sebastian Ochsenreither","raw_affiliation_strings":["Charit\u00e9 Comprehensive Cancer Center, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charit\u00e9 Comprehensive Cancer Center, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007525817","display_name":"Erika Richtig","orcid":"https://orcid.org/0000-0002-5505-6103","observed_orcids":["https://orcid.org/0000-0002-5505-6103"]},"institutions":[{"id":"https://openalex.org/I202276237","display_name":"Medical University of Graz","ror":"https://ror.org/02n0bts35","country_code":"AT","type":"education","lineage":["https://openalex.org/I202276237"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Erika Richtig","raw_affiliation_strings":["Medical University of Graz, Graz, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Graz, Graz, Austria","institution_ids":["https://openalex.org/I202276237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023198820","display_name":"Ioannis Thomas","orcid":"https://orcid.org/0000-0002-2822-2057","observed_orcids":["https://orcid.org/0000-0002-2822-2057"]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ioannis Thomas","raw_affiliation_strings":["University Clinic T\u00fcbingen, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Clinic T\u00fcbingen, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210094118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103703859","display_name":"Michael A. Erdmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088053","display_name":"Universit\u00e4tsklinikum Erlangen","ror":"https://ror.org/0030f2a11","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael Erdmann","raw_affiliation_strings":["University Hospital Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I4210088053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025478490","display_name":"C\u00e9l\u00e8ste Lebb\u00e9","orcid":"https://orcid.org/0000-0002-5854-7290","observed_orcids":["https://orcid.org/0000-0002-5854-7290"]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Celeste Lebbe","raw_affiliation_strings":["H\u00f4pital Saint Louis, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Saint Louis, Paris, France","institution_ids":["https://openalex.org/I4210144610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058642751","display_name":"Juan Mart\u00edn-Liberal","orcid":"https://orcid.org/0000-0003-2552-5172","observed_orcids":["https://orcid.org/0000-0003-2552-5172"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan Martin-Liberal","raw_affiliation_strings":["Catalan Institute of Oncology (ICO), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Catalan Institute of Oncology (ICO), Barcelona, Spain","institution_ids":["https://openalex.org/I4210107147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004458225","display_name":"Patrick Andres Maximilian Terheyden","orcid":"https://orcid.org/0000-0002-5894-1677","observed_orcids":["https://orcid.org/0000-0002-5894-1677"]},"institutions":[{"id":"https://openalex.org/I9341345","display_name":"University of L\u00fcbeck","ror":"https://ror.org/00t3r8h32","country_code":"DE","type":"education","lineage":["https://openalex.org/I9341345"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Patrick Terheyden","raw_affiliation_strings":["University of L\u00fcbeck, L\u00fcbeck, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of L\u00fcbeck, L\u00fcbeck, Germany","institution_ids":["https://openalex.org/I9341345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084070841","display_name":"Artem Poltoratskiy","orcid":"https://orcid.org/0000-0003-3259-2242","observed_orcids":["https://orcid.org/0000-0003-3259-2242","https://orcid.org/0000-0002-7650-1122"]},"institutions":[{"id":"https://openalex.org/I4210116304","display_name":"Institute of Oncology NN Petrov","ror":"https://ror.org/01mfpjp46","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210116304","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Artem Poltoratskiy","raw_affiliation_strings":["National Medical Research Oncology Center n.a. N.N. Petrov, Saint Petersburg, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Medical Research Oncology Center n.a. N.N. Petrov, Saint Petersburg, Russian Federation","institution_ids":["https://openalex.org/I4210116304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043771424","display_name":"Marina I Sekacheva","orcid":"https://orcid.org/0000-0003-0015-7094","observed_orcids":["https://orcid.org/0000-0003-0015-7094"]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Marina Sekacheva","raw_affiliation_strings":["Sechenov University, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sechenov University, Moscow, Russian Federation","institution_ids":["https://openalex.org/I17877952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027768345","display_name":"Yuliya Semiletova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuliya Semiletova","raw_affiliation_strings":["Clinic of advanced medical technologies n. a. Nicolay I. Pirogov, Saint Petersburg, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic of advanced medical technologies n. a. Nicolay I. Pirogov, Saint Petersburg, Russian Federation","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056227404","display_name":"Thomas Eigentler","orcid":"https://orcid.org/0000-0003-0019-2770","observed_orcids":["https://orcid.org/0000-0003-0019-2770"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Thomas Eigentler","raw_affiliation_strings":["Charit\u00e9 Medical University, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charit\u00e9 Medical University, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004881462","display_name":"Beate Schmitt-Bormann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123470","display_name":"CureVac (Germany)","ror":"https://ror.org/02q3n2241","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210123470"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Beate Schmitt-Bormann","raw_affiliation_strings":["CureVac AG, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CureVac AG, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210123470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077924082","display_name":"Dominik Vahrenhorst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123470","display_name":"CureVac (Germany)","ror":"https://ror.org/02q3n2241","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210123470"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dominik Vahrenhorst","raw_affiliation_strings":["CureVac AG, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CureVac AG, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210123470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021736614","display_name":"Sarah-Katharina Kays","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123470","display_name":"CureVac (Germany)","ror":"https://ror.org/02q3n2241","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210123470"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sarah-Katharina Kays","raw_affiliation_strings":["CureVac AG, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CureVac AG, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210123470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010492039","display_name":"Tobias Seibel","orcid":"https://orcid.org/0009-0004-9115-3228","observed_orcids":["https://orcid.org/0009-0004-9115-3228"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tobias Seibel","raw_affiliation_strings":["Charit\u00e9 Medical University, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charit\u00e9 Medical University, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060328208","display_name":"Gianluca Quintini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123470","display_name":"CureVac (Germany)","ror":"https://ror.org/02q3n2241","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210123470"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gianluca Quintini","raw_affiliation_strings":["CureVac AG, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CureVac AG, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210123470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112453456","display_name":"Birgit Scheel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123470","display_name":"CureVac (Germany)","ror":"https://ror.org/02q3n2241","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210123470"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Birgit Scheel","raw_affiliation_strings":["CureVac AG, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CureVac AG, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210123470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060727011","display_name":"Martin Falk","orcid":"https://orcid.org/0000-0003-0518-6513","observed_orcids":["https://orcid.org/0000-0003-0518-6513"]},"institutions":[{"id":"https://openalex.org/I4210123470","display_name":"CureVac (Germany)","ror":"https://ror.org/02q3n2241","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210123470"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Falk","raw_affiliation_strings":["CureVac AG, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CureVac AG, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210123470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054698965","display_name":"Ulrike Gnad-Vogt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123470","display_name":"CureVac (Germany)","ror":"https://ror.org/02q3n2241","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210123470"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ulrike Gnad-Vogt","raw_affiliation_strings":["CureVac AG, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CureVac AG, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210123470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047590296","display_name":"Paula Cod\u00f3","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123470","display_name":"CureVac (Germany)","ror":"https://ror.org/02q3n2241","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210123470"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Paula Cod\u00f3","raw_affiliation_strings":["CureVac AG, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CureVac AG, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210123470"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A816","last_page":"A816"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intratumoral-injection","display_name":"intratumoral injection","score":0.6029999852180481},{"id":"https://openalex.org/keywords/anti-pd-1-combination-therapy","display_name":"anti-PD-1 combination therapy","score":0.8529999852180481},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/immune-profiling","display_name":"immune profiling","score":0.6700000166893005},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9769999980926514},{"id":"https://openalex.org/keywords/immune-infiltration","display_name":"immune cell infiltration","score":0.8659999966621399},{"id":"https://openalex.org/keywords/interferon-response","display_name":"interferon response","score":0.6959999799728394},{"id":"https://openalex.org/keywords/immune-related-gene-expression","display_name":"immune gene expression","score":0.6779999732971191},{"id":"https://openalex.org/keywords/multiplex-immunofluorescence","display_name":"multiplex immunofluorescence","score":0.7860000133514404},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5260000228881836}],"concepts":[{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.6962972283363342},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6517398357391357},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.6043054461479187},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5946100950241089},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5873829126358032},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5724560022354126},{"id":"https://openalex.org/C2781188995","wikidata":"https://www.wikidata.org/wiki/Q6934982","display_name":"Multiplex","level":2,"score":0.4300157427787781},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3666592836380005},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36653679609298706},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3611326217651367},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3367471694946289},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.31624406576156616},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19664430618286133},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.08890315890312195}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2022-sitc2022.0784","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0784","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0784","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A816.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2022-sitc2022.0784","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.0784","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0784","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A816.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308403161.pdf","grobid_xml":"https://content.openalex.org/works/W4308403161.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W1943823376","https://openalex.org/W2581994937"],"related_works":["https://openalex.org/W3212762266","https://openalex.org/W4308406944","https://openalex.org/W3099100880","https://openalex.org/W3203724144","https://openalex.org/W3031389308","https://openalex.org/W2953665547","https://openalex.org/W4407131955","https://openalex.org/W2979215867","https://openalex.org/W2898334734","https://openalex.org/W4404052787"],"abstract_inverted_index":{"Background":[0],"CV8102":[1,38,98,115,278],"is":[2,31,648],"a":[3,9,27,48,119,308,395],"non-coding,":[4],"non-capped":[5],"RNA":[6,140],"complexed":[7],"with":[8,41,54,101,122,301,394],"carrier":[10],"peptide":[11],"activating":[12],"the":[13,33,60,65,89,152,158,227,236,241,263,290,298,419,466,484,523,537,541,574,577,600,605,612,615,621,629,645,653],"innate":[14],"(via":[15],"TLR7/8,":[16],"RIG-I)":[17],"and":[18,72,105,138,147,174,192,224,259,293,357,638],"adaptive":[19],"immune":[20,84,135,181,218,242,256,283,305],"system.1,":[21],"2":[22],"An":[23],"ongoing":[24],"expansion":[25,71,90,264],"of":[26,37,114,127,157,165,253,271,277,282,304,310,509,522,525,527,536,540,573,576,592,599,602,604,614,620,635,644,655],"phase":[28,73],"I":[29,439],"trial":[30],"investigating":[32],"intratumoral":[34],"(i.t.)":[35],"administration":[36],"in":[39,52,99,125,212,235,240,247,286,297,307,426,474],"patients":[40,96,107],"advanced":[42],"cutaneous":[43],"melanoma":[44],"(cMEL),":[45],"either":[46],"as":[47,77,108],"single":[49,109],"agent":[50],"or":[51,103,413],"combination":[53,100],"systemic":[55,217],"anti-PD-1":[56,93],"antibody":[57],"therapy.":[58],"In":[59,421,431,445,469,483],"initial":[61],"dose":[62,67,292],"escalation":[63],"part,":[64],"recommended":[66],"for":[68,132,262,633,650],"subsequent":[69],"cohort":[70],"II":[74],"was":[75,409,631],"defined":[76],"600":[78],"mg.":[79],"Here":[80],"we":[81],"report":[82],"preliminary":[83],"profiling":[85,196],"results.":[86],"Methods":[87],"For":[88,155],"cohorts,":[91],"30":[92],"refractory":[94],"Melanoma":[95],"received":[97],"Pembrolizumab":[102],"Nivolumab":[104],"10":[106],"agent.":[110],"Eight":[111],"i.t.":[112],"injections":[113],"were":[116,143,170,183],"administered":[117],"over":[118],"12-week":[120],"period,":[121],"optional":[123],"continuation":[124],"case":[126],"clinical":[128],"benefit.":[129],"Blood":[130,207],"samples":[131],"flow":[133],"cytometry-based":[134],"cell":[136,243,257],"phenotyping":[137],"next-generation":[139],"sequencing":[141],"(RNAseq)":[142],"collected":[144],"at":[145,515,552,583],"baseline":[146],"multiple":[148],"time":[149],"points":[150],"during":[151,173],"treatment":[153],"period.":[154],"characterization":[156],"tumor":[159,299],"microenvironment":[160],"(TME),":[161],"core":[162],"needle":[163],"biopsies":[164,232],"injected":[166],"and/or":[167],"non-injected":[168],"lesions":[169],"taken":[171],"before,":[172],"after":[175,226,289,595],"treatment.":[176],"Changes":[177],"on":[178,418,481],"various":[179],"tumor-infiltrating":[180],"cells":[182],"assessed":[184],"by":[185,353,411,652],"multiplex":[186],"immunofluorescence":[187],"(MultiOmyx":[188],"<":[189],"sup":[190,202],">TM)":[191],"immune-related":[193],"gene":[194,248],"expression":[195,249],"using":[197],"nCounter\u00ae":[198],"Pan":[199],"Cancer":[200],"IO360<":[201],">TM":[203],"panel":[204],"(NanoString).":[205],"Results":[206],"RNAseq":[208],"analysis":[209,261],"showed":[210,233,294],"increase":[211],"several":[213,280],"transcripts":[214],"related":[215],"to":[216],"response":[219,284],"activation":[220],"like":[221],"interferon":[222],"alpha":[223],"gamma":[225],"first":[228,291],"dose.":[229],"Paired":[230],"serial":[231],"changes":[234,296],"TME,":[237],"not":[238],"only":[239],"infiltration":[244,306],"but":[245],"also":[246],"profiling.":[250],"Comprehensive":[251],"results":[252],"blood":[254,288],"RNAseq,":[255],"phenotyping,":[258],"tissue":[260],"cohorts":[265],"will":[266],"be":[267],"presented,":[268],"including":[269],"examples":[270],"individual":[272],"patients.":[273,311],"Conclusions":[274],"Intratumoral":[275],"injection":[276],"activated":[279],"pathways":[281],"detectable":[285],"peripheral":[287],"immunological":[295],"microenvironment,":[300],"increased":[302],"parameters":[303],"group":[309],"Trial":[312],"Registration":[313],"NCT03291002":[314],"References":[315],"[1]":[316],"Ziegler":[317],"A,":[318,371],"Soldner":[319],"C,":[320],"Lienenklaus":[321],"S,":[322,326,332,381],"Spanier":[323],"J,":[324,373,375],"Trittel":[325],"Riese":[327],"P,":[328,377],"Kramps":[329],"T,":[330],"Weiss":[331],"Heidenreich":[333,366],"R,":[334,367],"Jasny":[335,368],"E,":[336,369],"Guzm\u00e1n":[337],"CA,":[338],"Kallen":[339,382],"KJ,":[340,383],"Fotin-Mleczek":[341,384],"M,":[342],"Kalinke":[343],"U.":[344],"A":[345,386,642],"New":[346],"RNA-Based":[347],"Adjuvant":[348],"Enhances":[349],"Virus-Specific":[350],"Vaccine":[351],"Responses":[352],"Locally":[354],"Triggering":[355],"TLR-":[356],"RLH-Dependent":[358],"Effects.":[359],"J":[360,400],"Immunol.":[361],"2017;198(4):1595\u20131605.":[362],"doi:":[363,403],"10.4049/jimmunol.1601129":[364],"[2]":[365],"Kowalczyk":[370],"Lutz":[372],"Probst":[374],"Baumhof":[376],"Scheel":[378],"B,":[379],"Voss":[380],"M.":[385],"novel":[387],"RNA-based":[388],"adjuvant":[389],"combines":[390],"strong":[391],"immunostimulatory":[392],"capacities":[393],"favorable":[396],"safety":[397],"profile.":[398],"Int":[399],"Cancer.":[401],"2015;137(2):372\u201384.":[402],"10.1002/ijc.29402.":[404],"Ethics":[405,424,472,513,543,579,581,622],"Approval":[406],"The":[407],"study":[408],"approved":[410,480],"central":[412],"local":[414],"ethics":[415],"committees":[416],"depending":[417],"country:":[420],"Germany:":[422],"Central":[423,471],"Committees":[425],"Tuebingen,":[427],"Germany":[428],"under":[429,440,465,476],"785/2016AMG1.":[430],"France:":[432],"COMITE":[433],"DE":[434,449,451],"PROTECTION":[435],"DES":[436],"PERSONNES":[437],"SUD-EST":[438],"2019-49,":[441],"approval":[442,462],"dated":[443,545],"17-May-2019.":[444],"Spain:":[446],"CEC":[447],"COMIT\u00c9":[448],"\u00c9TICA":[450],"INVESTIGACI\u00d3N":[452],"CL\u00cdNICA":[453],"CON":[454],"MEDICAMENTOS":[455],"del":[456],"Hospital":[457],"Universitari":[458],"Vall":[459],"d\u2019Hebron,":[460],"Barcelona,":[461],"date":[463],"28-Nov-2019":[464],"EUdraCT":[467],"number.":[468],"Austria:":[470],"Committee":[473,514,544,582],"Graz":[475],"31-426":[477],"ex":[478],"18/19":[479],"19-Sep-2019.":[482],"Russian":[485,606],"Federation:":[486],"ETHICS":[487,507,550],"COMMITTEE":[488,508,551],"AT":[489],"FSBI":[490],"\u201dNMRC":[491],"OF":[492,497,500,502,556],"ONCOLOGY":[493],"n.a.":[494],"N.N.":[495],"BLOKHIN\u201d":[496],"THE":[498,503],"MINISTRY":[499],"HEALTHCARE":[501],"RUSSIAN":[504],"FEDERATION,":[505],"INTERDISCIPLINARY":[506],"Omsk":[510],"Region,":[511],"Local":[512,542],"FSAEI":[516],"HE":[517],"\u201dI.M.":[518],"Sechenov":[519],"First":[520],"MSMU\u201d":[521],"Ministry":[524,601],"Healthcare":[526],"Russia":[528],"(Sechenov":[529],"University,":[530],"Extract":[531],"from":[532,611,628],"Minutes":[533,613],"\u2116":[534,571],"03-21":[535],"scheduled":[538],"meeting":[539,575],"03":[546],"February":[547],"2021),":[548],"BIOMEDICAL":[549],"N.I.":[553],"PIROGOV":[554],"CLINIC":[555],"HIGH":[557],"MEDICAL":[558],"TECHNOLOGIES":[559],"(IN-PATIENT":[560],"AND":[561],"OUTPATIENT":[562],"FACILITIES),":[563],"ST.":[564],"PETERSBURG":[565],"STATE":[566],"UNIVERSITY":[567],"(EXTRACT":[568],"FROM":[569],"MINUTES":[570],"02/21":[572],"Biomedical":[578],"Committee),":[580],"Federal":[584],"State":[585],"Budgetary":[586],"Institution":[587],"\u201cNational":[588],"Medical":[589],"Research":[590],"Center":[591],"Oncology":[593],"named":[594],"N.":[596,597],"Petrov\u2032\u2032":[598],"Health":[603],"Federation":[607],"(Extract":[608],"No.":[609,618],"5/130":[610],"regular":[616],"session":[617],"8":[619],"Committee).":[623],"Consent":[624],"Written":[625],"informed":[626],"consent":[627,647],"patient":[630],"obtained":[632],"publication":[634],"this":[636,656],"abstract":[637],"any":[639],"accompanying":[640],"images.":[641],"copy":[643],"written":[646],"available":[649],"review":[651],"Editor":[654],"journal.":[657]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2022-11-11T00:00:00"}